Press "Enter" to skip to content

New patent expiration for Padagis Us drug EVAMIST

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Padagis Us drug EVAMIST

Annual Drug Patent Expirations for EVAMIST
Annual Drug Patent Expirations for EVAMIST

Evamist is a drug marketed by Padagis Us and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

EVAMIST drug price trends.

Drug patent litigation for EVAMIST.

This drug has seventeen patent family members in ten countries.

The generic ingredient in EVAMIST is estradiol. One supplier is listed for this compound. Additional details are available on the estradiol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Padagis Us drug EVAMIST
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions